Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,590.88
(
-0.51%
)
US TECH 100
23,645.60
(
-0.63%
)
Dow Jones
45,945.41
(
-0.61%
)
Brent Oil
107.49
(
0.85%
)
Bitcoin
69,550.92
(
-2.37%
)
News Focus
News Focus
Post# of 257259
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122797
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: jq1234 post# 158957

Wednesday, 03/27/2013 10:40:01 PM

Wednesday, March 27, 2013 10:40:01 PM

Post# of 257259

FDA denied TEVA's CP regarding new MS drug approval without input from adcom...

The quick (<3 months) FDA turnaround on Teva’s rejected CP is clearly tied to the approval of Tecfidera.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now